Development of a protocol for maintaining viability while shipping organoid-derived retinal tissue

Ratnesh K Singh1, Paige Winkler2, Francois Binette1

  • 1Research & Development, Lineage Cell Therapeutics, Inc, Alameda, CA.

Summary

We developed a shipping protocol for human pluripotent stem cell-derived retinal tissue. This enables remote collaboration for regenerative medicine, advancing treatments for blindness.

Related Concept Videos